|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced stage Ⅲb or Ⅳ nonsmall cell lung carcinoma treated with carboplatin and paclitaxel显示文摘 | Hensing TA Peterman AH Schell MJ | 2003 | Cancer2003，98，4： | 1 |
| 2 | Measuring spiritual wellbeing in people with cancer:the functional assessment of chronic illness therapy-Spiritual Well-being Scale (FACIT-Sp) 显示文摘 | Peterman AH Fitehett G Brady M J | 2002 | Ann Behav Med JT-Annals of behavioral medicine:a publication of the Society of Behavioral Medicine2002，24，1： | 1 |
| 3 | A case for including spirituality in quality of life measurement in oncology 显示文摘 | Brady MJ Peterman AH Fitchett G | 1999 | Psy- cho -oncology1999，8，5： | 1 |
| 4 | The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage ⅢB or Ⅳ non-small cell lung carcinoma treated with carboplatin and paclitaxel 显示文摘 | Hensing TA Peterman AH Schell M J | 2003 | Cancer2003，98，4： | 1 |
| 5 | The impact of age on toxicity,response rate,quality of life,and survival in patients with advanced stage Ⅲb or Ⅳ non-small cell lung carcinoma treated with carboplatin and paclitaxel显示文摘 | Hensing TA Peterman AH Schell MJ | 2003 | Cancer2003，98，4： | 1 |
| 6 | A case for including spirituality in quality of life measurement in oncology显示文摘 | Brady MJ Peterman AH Fitchett G | 1999 | Psyco Oncology1999，8，5： | 1 |
| 7 | The impact of age on toxicity,response rate,quality of life,and survival in patients with advanced stage Ⅲ b or Ⅳ nonsmall cell lung carcinoma,treated with carboplatin and paclitaxel显示文摘 | Hensing TA Peterman AH Schell MI | 2003 | Cancer2003，98，： | 1 |
| 8 | Ⅲ trialcomparing a defined duration of therapy VelSU8 continuous therapy followed by second-line therapy in advanced-stage Ⅲ b/Ⅳ non-small-cell lung cancer显示文摘 | Socinski MA Schell MJ Peterman AH | 2002 | J Clin Oncol2002，20，： | 1 |
| 9 | Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument 显示文摘 | Peterman AH CeUa D Mo F | 1997 | Quality of Life Research1997，6，6： | 1 |
| 10 | The impact of age on toxicity,response rate,quality of life,and survival in patients with advanced,Stage IIIB or IV non small cell lung carcinoma treated with carboplatin an paclitaxel显示文摘 | Hensing TA Peterman AH Schell MJ | 2003 | Cancer2003，98，4： | 1 |
| 11 | The impact of age on toxicity,response rate,quality Of life,and survival in patients with advanced stage m B or Ⅳ nonsmall cell lung carcinoma treated with carboplatin and paclitaxel 显示文摘 | Hensing TA Peterman AH Schell MJ | 2003 | Cancer2003，98，： | 1 |
| 12 | The impact of age on toxicity, response rate ,quality of llfe and survival in patients with advanced stage Ⅲ b or IV non-small cell lung carcinoma treated with carboplatin and paditaxel 显示文摘 | HENSING TA PETERMAN AH SCHELL MJ | 2003 | Cancer2003，98，4： | 1 |
| 13 | The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage ⅢB or Ⅳ nonsmall cell lung carcinoma triated with carboplatin and paclitaxel显示文摘 | Thomas HA Peterman AH Schell MJ | 2003 | Cancer2003，98，4： | 1 |
| 14 | A randomized phase Ⅱ trial of first-line treatment with gemcitabine, erlotin- ib, or gemcitabine and erlotinib in elderly patients (age γ: 70 years) with stage Ⅲ B/Ⅳ non small cell lung cancer显示文摘 | Stinchcombe TE Peterman AH Lee CB etal | 2011 | J Thorac Oncol2011，6，9： | 1 |
| 15 | The impact of age on toxicity , response rate, quality of life, and survival in patients with advanced, stage m b or IV nonsrnall cell lung carcinoma treated with carboplatin and pacJitaxel 显示文摘 | Hensing TA Peterman AH Schell MJ | 2003 | Cancer2003，98，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员